KALININGRAD, RUSSIA – DECEMBER 4, 2020: A nurse fills in a syringe as she prepares to give a serviceman of the Russian Navy’s Baltic Fleet the Russian Sputnik V vaccine during COVID-19 vaccination. Vitaly Nevar/TASS Ðîññèÿ. Êàëèíèíãðàä. Âî âðåìÿ âàêöèíàöèè îò êîðîíàâèðóñà ðîññèéñêîé âàêöèíîé “Ñïóòíèê V” âîåííîñëóæàùèõ Áàëòèéñêîãî ôëîòà. Âèòàëèé Íåâàð/ÒÀÑÑ

MOSCOW, December 4. /TASS/. Russian Direct Investment Fund (RDIF) said on Friday it had signed an agreement on cooperation for the accelerated registration, production and distribution of the Russian Sputnik V anti-coronavirus vaccine with Kazakhstan’s Health Ministry.

“Thanks to the agreement between the RDIF and Kazakhstan, the population of this country will have access to the anti-coronavirus vaccine with the efficiency of more than 91%. Production of the Sputnik V vaccine that will be organized in Kazakhstan will make it possible to reduce logistic costs and ensure supplies of the vaccine to medical establishments in a short period of time. Apart from that, the agreements will make it possible to expand exchange of technologies, research and medical experience between our countries,” RDIF quoted its CEO Kirill Dmitriev as saying.

After Kazakhstan’s regulating agencies issue an approval, technology transfer will be carried out and material for the production of at least two million doses of the Sputnik V vaccine will be supplied to Kazakhstan.

On August 11, Russia registered the world’s first vaccine against the novel coronavirus. The vaccine, dubbed Sputnik V, was developed by the Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Health Ministry. Its clinical trials were successfully completed in June-July. The Russian Health Ministry said on August 15 that production of the vaccine had been launched. The third, post-registration, stage of clinical tests began in Moscow on September 7. Volunteers were inoculated with the first dose of the vaccine on September 9. As many as 40,000 people are involved in the trials, with 10,000 of them being inoculated with a placebo.

According to the third phase results, the vaccine’s efficiency is 91.4%.

Currently, third phase tests are underway in Belarus, the United Arab Emirates, Venezuela, and a number of other countries, while second and third phase trials are being carried out in India.

Orders for more than 1.2 billion doses of the Sputnik V vaccine have come from more than 50 countries. International partners of the Russian Direct Investment Fund in India, Brazil, China, South Korea and in four more states will manufacture the vaccine.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

China’s largest cargo airline expands fleet to 63

BEIJING – SF Airlines, China’s largest air cargo carrier, has expanded its all-cargo freighter fleet to 63 aircraft, the airline announced on Monday. A newly converted B767-300F all-cargo freighter joined the fleet on Monday, said SF Airlines. It is the…

7 tips to make you a Slack power user

New York (CNN Business)For years, Slack has been popular among tech startups, media companies and retailers as a tool for employees to chat and collaborate. But as many people have shifted to working from home during the pandemic, services like…

Elon Musk’s net worth plunged by $16.3 billion in a single day

Elon Musk’s net worth took a steep nosedive on Tuesday, plummeting by more than $16 billion in one day after Tesla stock tumbled. The Tesla chief executive, who owns about 20% of the electric carmaker’s shares, saw his personal wealth…

Global carriers adopt innovative measures to stay afloat

Global air carriers are adopting various innovative measures to increase revenue and stay afloat amid difficulties due to COVID-19. Before the contagion, it was expected that 4.7 billion passenger trips would take place around the world this year. However, due…